BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nissen LHC, Derikx LAAP, Jacobs AME, van Herpen CM, Kievit W, Verhoeven R, van den Broek E, Bekers E, van den Heuvel T, Pierik M, Rahamat-langendoen J, Takes RP, Melchers WJG, Nagtegaal ID, Hoentjen F, de Jonge EEC, Natte R, Nijhuis EWP, Peutz-kootstra C, Roelofs JJTH, Willems SM, Willig AP, van Bodegraven AA, Tan ACITL, Meeuse JJ, van der Meulen–de Jong AE, Oldenburg B, Loffeld BCAJ, Durfeld BM, van der Woude CJ, Cahen DL, D’haens G, Janik D, Mares WGM, Gilissen LPL, Wolters FL, Dijkstra G, Erkelens GW, Tang TJ, Breumelhof R, Smalbraak HJT, Thijs JC, Voskuil JH, Kuyvenhoven JP, Vecht J, Rijk MCM, Janssen JM, Sarneel JT, Tjhie-wensing JWM, Lai JYL, Vlasveld LT, Oostenbrug LE, Gerretsen M, Van Herwaarden MA, Mahmmod N, Russel MGVM, Grubben MJAL, Vu MK, Verhulst ML, Dewint P, Stokkers PCF, Bus PJ, Wismans PJ, van der Haeck PWE, Stuyt RJL, Zeijen RNM, Dahlmans RPM, Vandebosch S, Romkens TEH, Moolenaar W, ten Hove WR, Boot H, van der Linde K, Wahab P, de Boer SY, Thurnau K, Thijs WJ, Josemanders DFGM, West RL, Pierik MJ, Depla ACTM, Keulen ETP, de Boer WA, Naber AHJ, Vermeijden JR, Mallant-hent RC, Beukers R, Ter Borg PCJ, Halet ECR, Bruin KF, Linskens RK, Bruins Slot W; The Dutch Initiative on Crohn and Colitis (ICC), Dutch Head and Neck Society, PALGA group, IBD/HNC group. Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study. Inflammatory Bowel Diseases 2018;24:2015-26. [DOI: 10.1093/ibd/izy096] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Carman N, Mack DR, Benchimol EI. Anticipatory care of children and adolescents with inflammatory bowel disease: a primer for primary care providers. Curr Opin Pediatr 2019;31:654-60. [PMID: 31205126 DOI: 10.1097/MOP.0000000000000795] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Pillai A, Adilbay D, Matsoukas K, Ganly I, Patel SG. Autoimmune disease and oral squamous cell carcinoma: A systematic review. J Oral Pathol Med 2021. [PMID: 34145639 DOI: 10.1111/jop.13218] [Reference Citation Analysis]
3 van de Ven SEM, Derikx LAAP, Nagtegaal ID, van Herpen CM, Takes RP, Melchers WJG, Pierik M, van den Heuvel T, Verhoeven RHA, Hoentjen F, Nissen LHC. Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors. Inflamm Bowel Dis 2020;26:1060-7. [PMID: 31559415 DOI: 10.1093/ibd/izz210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Chen G, Xie J, Liang T, Wang Y, Liao W, Song L, Zhang X. Inflammatory Bowel disease promote oral cancer and pharyngeal cancer: new evidence of Mendelian randomization. Acta Otolaryngol 2022;142:191-6. [PMID: 35195051 DOI: 10.1080/00016489.2022.2035431] [Reference Citation Analysis]
5 Mala A, Foteinogiannopoulou K, Koutroubakis IE. Solid extraintestinal malignancies in patients with inflammatory bowel disease. World J Gastrointest Oncol 2021; 13(12): 1956-1980 [DOI: 10.4251/wjgo.v13.i12.1956] [Reference Citation Analysis]
6 Pillai A, Valero C, Zanoni D, Navas K, Morris Q, Ganly I, Patel SG. Prognostic impact of autoimmune disease in oral cavity squamous cell carcinoma. Journal of Surgical Oncology. [DOI: 10.1002/jso.27017] [Reference Citation Analysis]
7 Hamilton SN, Urban R, Liu A, Chau N, Berthelet E, Tran E, Wu J, Yin Y, Olson R. Population-based outcomes by immunosuppressed status in patients undergoing radiotherapy for oropharyngeal cancer. Radiother Oncol 2020;151:110-7. [PMID: 32798599 DOI: 10.1016/j.radonc.2020.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Le Naour J, Sztupinszki Z, Carbonnier V, Casiraghi O, Marty V, Galluzzi L, Szallasi Z, Kroemer G, Vacchelli E. A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients. OncoImmunology 2022;11:2059878. [DOI: 10.1080/2162402x.2022.2059878] [Reference Citation Analysis]
9 Pillai A, Valero C, Navas K, Morris Q, Patel SG. Peripheral blood values as predictors of autoimmune status in oral cavity squamous cell carcinoma. Transl Oncol 2021;14:101220. [PMID: 34521033 DOI: 10.1016/j.tranon.2021.101220] [Reference Citation Analysis]